Share Name Share Symbol Market Type Share ISIN Share Description
Standard Life Uk Smaller Companies Trust Plc LSE:SLS London Ordinary Share GB0002959582 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -4.00 -0.72% 553.00 548.00 558.00 556.00 552.00 552.00 259,050 16:35:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 6.7 6.7 82.0 408

Standard Life Uk Smaller... Share Discussion Threads

Showing 51 to 74 of 75 messages
Chat Pages: 3  2  1
Harry Nimmo’s record is really good - this has outperformed most others in this sector over any decent period of time. It’s one of my largest holdings, have about 10% of my holdings in this one.
dr biotech
UK small-caps: themes from a crisis – by Harry Nimmo, Manager of Standard Life UK Smaller Companies Trust plc HTTPS://
From today's Tempus column in the Times... HTTPS:// The challenges that have faced the Standard Life UK Smaller Companies Trust in the past couple of years are clear for all to see (Greig Cameron writes). Its financial year runs to June 30, so its 2019 results were affected by the sell-off in stock markets near the end of 2018; this year’s results, published last week, took into account the initial impact of Covid-19. The resulting two years of negative absolute returns could be a cause for concern for some investors, perhaps, but look a little deeper and the trust has comfortably outperformed its benchmark — the Numis Smaller Companies plus Aim index, excluding investment companies — in both periods. And having seen the value of its portfolio dive by close to 40 per cent in March, a net asset value total return of -0.5 per cent over the full year to the end of June underlines the recovery in equities post-lockdown. Harry Nimmo has run the trust since 2003 and oversaw an expansion in 2018, when it was merged with Dunedin Smaller Companies Investment Trust. He and his team have a strong record of solid returns, with an average of 15.6 per cent annual growth since they took over. The aim is to pick the best of UK smaller and mid-cap companies with a long-term view. Mr Nimmo, 63, states that the principles of “risk-aversion, resilience, growth and momentum” have not changed and that the pandemic may actually accelerate trends beneficial for smaller companies. However, “with the potential for further spikes in Covid outbreaks, a vaccine some way off and a difficult negotiation on Brexit ahead, the recovery may be punctuated by setbacks”. Digital businesses are a favourite, with Kainos, the software developer, Gamma Communications, a telecoms company, and Future, the magazine and online publisher, among its biggest holdings. The 7.7p dividend was flat year-on-year, with the trust dipping into its revenue reserves to maintain it at that level. The shares entered 2020 at more than 630p, but halved to 314p in March. A recovery since then means that the shares are now changing hands for about 540p. ADVICE: Hold WHY: Growth potential for patient investors
now at back to discount .
SLS now powering ahead and now at a premium ?
Yes, but in a falling market if people sell the open ended funds then the manager may have to make a fire sale, but the trust can hold on and sell when they like. Just have to look at Woodfords WEIF to see what a disaster that can be - ie locked in and still paying fees. I have a few of these - Harry Nimmos record is pretty good.
dr biotech
The fees are a question mark. HL say the SL smaller UK companies fund has total charges of 1.23% whereas this trust is listed as 1.93%. The NAV discount isn't a winner over time if the fees are greater.....
I hold the Standard Life UK Smaller Company fund but charted this against it and see it's pretty much the same and also run by Harry Nimmo. Thing is this is trading at a 8.5% discount to the NAV. I realise in theory the discount could widen, but are there any other downsides to me swapping to these?
A very quiet BB. Often a good sign. Just read the annual report. There is no doubt in my mind that this is a high quality undervalued trust. Harry Nimo is a good manager and has avoided the blue sky disasters. Small company trusts are always on a discount, but it’s not really warranted. On my ADD list.
Added today on a 7% discount,normally they start to buy back at 8% discount,have beaten their respective indices by a wide % overtime.
contrarian joe
See the latest ADVFN twitter poll about Funds:
Discount on SDV is also quite wide based on their historical average. Not really sure why, the discount seems to vary randomly with some obvious exceptions such as the brexit vote. I think buying trusts based on their discounts is the way to go as they will always narrow, but of course you have also got to like what’s in them.
dr biotech
Yes, I'm in this trust and Dunedin Smaller Companies, so will be doubling up when that goes through. A well run trust. Discount probably widening on small companies as we are near the top of the market. Happy to hold this long term though.
Discount here near it’s max, long term averages more than 10% I am in. Will add 2k a month. Anyone else around?
dr biotech
'Standard Life UK Smaller Companies and FRC Meetings' Blog post available here: hTTps://
lot of buys
This week's Investors Chronicle gives this a buy.
nice! did they mention a price target?
It was recommended in this weekends Telegraph. Mentioned about the discount and the long-term performance. I have purchased some more this has done very well for me
nice rise today tiger hope you are still dripping!
I've got my doubts. Nimo said this in his latest report: "From the start of the Company's financial year until 6 March 2014, the market was happy to take on risk and in particular support high growth companies, with valuation a secondary consideration. In general, markets took the view that the smaller the stock, the better the performance. This is typical of a bull market: stocks exhibiting earnings and price momentum were favoured. All this was supported by a buoyant economic backdrop, especially in the UK, but also in the US. Indeed an unusually strong confluence of economic growth and recovery was evident all round the world including Japan, China and even continental Europe. This was a vintage period for smaller companies, with this part of the market up by 27% in the period to 6 March 2014. Following that date and Fed Chair Yellen's comments, investors, including the increasingly influential multi-asset, global macro segment, moved to reduce risk by exiting small and mid sized companies. This was often achieved by indirect methods such as derivatives or selling exchange traded funds (ETFs). This, in turn, caused selling in the underlying holdings and prompted downwards share price pressure in particular on the smaller constituents of the FTSE 250 which also coincide with some of our larger holdings. At the same time the new issues market was unusually active, particularly with retail new issues. Fund managers who wish to participate in these new issues tend to sell previous winners, especially existing retail holdings. High growth stocks which did particularly well in the preceding period were sold due to being seen as high risk. The microcap segment, in which this Company is only a small participant, was exempt from this major rotation as there are no derivatives in this part of the market. Microcaps were not weighed down by new issues. Indeed, there were strong money flows into this sub-sector during the year." ............................................................................... imho, at a coming of a correction or long period of consolidation high PER/high PEG growth stocks tend to sell off faster than income stocks. Smaller UK Funds are generally high PER/high PEG growth stocks which are the first to go risk-off. Hence year to date, SLS & BRSC are down 13% while SDV is only down 2%. Unit trusts low PER/low PEG, Slater Growth Fund & Marlborough Micro cap Fund have gained 12% & 6%, confirming Nimo's last two sentences.
Hopefully you're right. These went from trading at a premium to trading at a discount so the fall was exaggerated.
Looks like the pull back is over. Weekly candles: free stock charts from
What Investment - 18/7/14: Shock for investors as Harry Nimmo's UK Smaller Companies fund named on 'Spot the Dog' list Investors in Harry Nimmo's Standard Life Investments UK Smaller Companies fund, long a beacon for smaller companies investors, has been named on Bestinvest's 'Spot the Dog' list of funds to avoid. Bestinvest compiles its list of 'dog' funds for investors to avoid by looking for funds that have underperformed the benchmark in each of the past three years, and by a cumulative 10 per cent over the entire three-year period. Nimmo's fund has a sterling long-term track record, having delivered 738 per cent since 1997, compared to 371 per cent for the IMA UK Smaller Companies sector. But the past three years have been more challenging. The fund is ranked 50th out of 51 funds in its peer group over that time period, and is the absolute worst fund in the sector over the past 12 months. Jason Hollands, managing director at BestInvest, acknowledged the previous strong performance of the fund by commenting that he wouldn't be surprised if this was the only year in which it made the list of 'dog' funds. However, he added that the size of the fund, now over £1 billion, would make it more difficult for Nimmo to repeat the spectacular outperformance that its investors have enjoyed in the past.
simon gordon
Chat Pages: 3  2  1
ADVFN Advertorial
Your Recent History
Standard L..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201031 18:51:18